Developer docs
API playgroundTry for free, no card

Search company profiles

Meierbei.com

Full company profile

uuid0003uht

Namestring
Meierbei.com
Legal namestring
成都美尔贝科技股份有限公司 (Chengdu Meierbei Technology Co., Ltd.)
Websiteurl
meierbei.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Meierbei.com (美呗医美) is a Chengdu-headquartered, privately held medical aesthetics selection platform founded in 2011 by Gong Liansheng. The company operates as a two-sided marketplace that connects individual consumers seeking cosmetic procedures with 2,000+ partner medical institutions and 12,000+ licensed doctors across all 34 Chinese provinces, municipalities, and autonomous regions, with stated reach into overseas markets. The platform is positioned as a "high-end strict-selection" intermediary, using a 6-category, 26-item institutional review (less than 10% annual approval rate) and, since April 2021, a 6-dimension, 55-criteria "Mei Bei Diamond" tier (less than 1% acceptance rate) to curate supply. As of 2019, the platform had partnered with 39 of China's 51 nationally certified 5A medical aesthetic institutions, representing nearly 80% of that segment.

Underlying technology centers on an AI-driven recommendation and matching system layered with a machine-learning + human dual review mechanism for content authenticity and user privacy. The product surface includes a web portal (meb.com), iOS/Android mobile application, and a 350+ consultant workforce delivering 24/7 1-on-1 pre-, during-, and post-procedure consultation with up to 6 months of follow-up. Cumulative consultation volume has exceeded 80 million since founding.

Revenue is generated primarily through transaction/commission fees on consumer matches with partner institutions, supplemented by a premium membership tier offering priority consultation, special pricing, and enhanced after-sales concierge service. The company has raised approximately $18.8M in disclosed funding across rounds led by Cowin Capital (2015), Shenzhen Capital Group (2018), and Sichuan provincial government-affiliated investment funds (2019), with strategic partnerships including a 2020 alliance with hyaluronic acid manufacturer Bloomage Bio. Operational status is active, with no IPO or public listing disclosed.

Short descriptiontext

Meierbei.com is a Chengdu-based, privately held medical aesthetics selection platform founded in 2011 that connects individual Chinese consumers with 2,000+ vetted hospitals and 12,000+ licensed doctors via a curated, AI-assisted matching and 1-on-1 consultation model, generating revenue from platform commissions and premium memberships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChongqing, China
HQ citystring
Chongqing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetics platform, cosmetic surgery marketplace, aesthetic medicine selection, beauty service curation, plastic surgery consultation
NAICS code1 code
  • Beauty Salons812112
SIC code1 code
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Medical Aesthetics Marketplace
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Commission/Transaction Fee
TypeTransaction Fee
Description

As a medical aesthetics marketplace platform, Meierbei earns revenue by facilitating transactions between users and partner medical institutions. The platform connects users with 2000+ hospitals and 12,000+ doctors, earning commissions on successful matches and service completions.

meierbei.com
2Premium Membership Services
TypeSubscription Recurring
Description

High-end membership services providing exclusive benefits including priority consultation, special pricing, and enhanced after-sales support. Premium members receive dedicated concierge services throughout their medical aesthetics journey.

meierbei.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 4 records shown
1美呗网 (Meibei Website)
Description

Online medical aesthetics consulting service platform offering hospital/doctor comparison, pricing comparison, customized plans, and authentic product recommendations.

meierbei.com
+3 more records
Core offering1 text field

Meierbei.com is a high-end medical aesthetics selection platform that connects individual consumers with vetted partner hospitals and licensed doctors for cosmetic and plastic surgery procedures. The platform offers 1-on-1 pre-surgery, in-surgery, and post-surgery consultation services via 350+ professional aesthetics consultants, hospital/doctor matching, price comparison, customized treatment plans, authentic product verification, and after-sales follow-up.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Nearly 80% of China's 5A medical aesthetics institutions are partnered with Meierbei (39 out of 51)
+3 more records
Product overview1 text field

Meierbei.com operates as a unified medical beauty platform ecosystem consisting of three main products: the Meibei Medical Beauty Platform (美呗医美平台) as the core platform, the Meibei.com website (美呗网) as the web portal, and the Meibei mobile application (美呗APP) for on-the-go access. The platform functions as a medical aesthetic marketplace connecting users with over 2,000 partner hospitals and 12,000+ licensed doctors, offering services including 1-to-1 consultation, hospital selection, price comparison, and after-sales support across 34 provinces in China.

Product and service6 records
1Meibei Medical Beauty Platform (美呗医美平台)
CategoryMedical aesthetics marketplace platform
Description

The core online platform that helps users answer plastic surgery questions, filter quality hospitals, compare facility prices, customize medical aesthetic plans, and select authentic medical beauty projects. It is the primary product of the company.

2Meibei.com Website (美呗网)
CategoryWeb platform
Description

The official web portal of the Meibei medical beauty platform, providing browser-based access to medical consultation, hospital matching, price comparison, and service booking for individual consumers.

3Meibei Mobile App (美呗APP)
41-on-1 Medical Aesthetics Consultation Service
CategoryConsultation service
Description

A personalized consultation service delivered by 350+ professional medical aesthetics consultants, available 24/7 year-round, covering pre-surgery Q&A, in-surgery support, and up to 6 months of post-procedure follow-up, targeted at individual medical aesthetics consumers.

5Premium Membership Services (高端会员尊享服务)
6Meibei Diamond Institution List (美呗美钻机构榜单)
CategoryInstitution curation and ranking
Description

A premium curation/listing product launched in April 2021 that applies a 6-dimensional, 55-criteria evaluation framework with less than 1% acceptance rate to identify and rank top-tier medical aesthetics institutions for consumers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Hua Xi Bio (华熙生物)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

In 2020, Meierbei entered a strategic partnership with Hua Xi Bio, a leading hyaluronic acid manufacturer. The partnership focuses on product procurement, consumer demand analysis, and product design collaboration to ensure quality control and safety across all consumer touchpoints. This partnership supports Meierbei's 'Strict Selection of Authentic Products' initiative.

meierbei.com
2Partner Medical Institutions (2000+)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Meierbei partners with 2000+ compliant medical institutions across 34 provinces. All partner institutions must pass the 6-dimension, 26-criteria review with less than 10% annual approval rate. Nearly 80% of China's 5A medical aesthetics institutions (39 of 51) are partnered with Meierbei.

meierbei.com
3Partner Doctors (12000+)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Meierbei collaborates with 12,000+ qualified doctors who possess valid medical practitioner certificates (医师执业证 and 医师资格证). Foreign doctors must also hold the Foreign Doctor Short-term Practice Permit. Anesthesiologists are also required to have proper certifications.

meierbei.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

NASDAQ-listed Chinese medical aesthetics internet platform that facilitates user discovery of cosmetic treatment providers, doctor reviews, and bookings. Directly competes with Meierbei as the other major player in China's medical aesthetics marketplace space, serving the same consumer and institutional customers with a similar content-plus-matching model.

TypeBroad incumbent
Description

Global manufacturer of medical and aesthetic laser, light, and ultrasound devices used by clinics and medical aesthetic institutions. Operates upstream in the same value chain Meierbei intermediates, with reach into the same institutional clients.

TypeEmerging player
Description

Online consultation and matching platform that connects consumers with cosmetic doctors for virtual consultations and treatment planning. Overlaps with Meierbei's 1-on-1 pre-surgery consultation role, though focused on the US market and an earlier-stage offering.

TypeDirect peer
Description

Chinese medical aesthetics platform offering hospital discovery, doctor matching, and booking services. Competes head-on with Meierbei in the same domestic segment, targeting consumer demand for cosmetic procedure selection and comparison.

TypeBroad incumbent
Description

Global aesthetics pharmaceutical leader (Botox, fillers, skincare) supplying products consumed in aesthetic procedures. Adjacent to Meierbei's selective product supply chain and the institutions transacted on its platform.

TypeBroad incumbent
Description

Major Chinese digital health and pharmaceutical e-commerce platform operated by Alibaba. Overlaps with Meierbei in digitizing healthcare consumer journeys and could enter medical aesthetics matchmaking as part of its broader healthcare marketplace.

7RealSelf
TypeDirect peer
Description

US-based medical aesthetics platform providing doctor/institution discovery, reviews, and consumer education for cosmetic procedures. Operates a comparable content-led, trust-driven marketplace model targeting the same medical aesthetics consumer use case in a different geography.

8Bloomage Bio (华熙生物)
TypeOthers
Description

Leading Chinese hyaluronic acid manufacturer and an existing strategic partner of Meierbei (product procurement, demand analysis, design collaboration). Enables Meierbei's authentic-product selection pillar and represents an upstream supply relationship in the same industry value chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Meierbei.com

Medical Aesthetics Marketplacemeierbei.com

Meierbei.com is a Chengdu-based, privately held medical aesthetics selection platform founded in 2011 that connects individual Chinese consumers with 2,000+ vetted hospitals and 12,000+ licensed doctors via a curated, AI-assisted matching and 1-on-1 consultation model, generating revenue from platform commissions and premium memberships.

What Meierbei.com does

Meierbei.com (美呗医美) is a Chengdu-headquartered, privately held medical aesthetics selection platform founded in 2011 by Gong Liansheng. The company operates as a two-sided marketplace that connects individual consumers seeking cosmetic procedures with 2,000+ partner medical institutions and 12,000+ licensed doctors across all 34 Chinese provinces, municipalities, and autonomous regions, with stated reach into overseas markets. The platform is positioned as a "high-end strict-selection" intermediary, using a 6-category, 26-item institutional review (less than 10% annual approval rate) and, since April 2021, a 6-dimension, 55-criteria "Mei Bei Diamond" tier (less than 1% acceptance rate) to curate supply. As of 2019, the platform had partnered with 39 of China's 51 nationally certified 5A medical aesthetic institutions, representing nearly 80% of that segment.

Underlying technology centers on an AI-driven recommendation and matching system layered with a machine-learning + human dual review mechanism for content authenticity and user privacy. The product surface includes a web portal (meb.com), iOS/Android mobile application, and a 350+ consultant workforce delivering 24/7 1-on-1 pre-, during-, and post-procedure consultation with up to 6 months of follow-up. Cumulative consultation volume has exceeded 80 million since founding.

Revenue is generated primarily through transaction/commission fees on consumer matches with partner institutions, supplemented by a premium membership tier offering priority consultation, special pricing, and enhanced after-sales concierge service. The company has raised approximately $18.8M in disclosed funding across rounds led by Cowin Capital (2015), Shenzhen Capital Group (2018), and Sichuan provincial government-affiliated investment funds (2019), with strategic partnerships including a 2020 alliance with hyaluronic acid manufacturer Bloomage Bio. Operational status is active, with no IPO or public listing disclosed.

Meierbei.com firmographics

Firmographics
Name
Meierbei.com
Legal name
成都美尔贝科技股份有限公司 (Chengdu Meierbei Technology Co., Ltd.)
Website
https://meierbei.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Meierbei.com is a Chengdu-based, privately held medical aesthetics selection platform founded in 2011 that connects individual Chinese consumers with 2,000+ vetted hospitals and 12,000+ licensed doctors via a curated, AI-assisted matching and 1-on-1 consultation model, generating revenue from platform commissions and premium memberships.
Ownership category
akta.pro rank

Where Meierbei.com is headquartered

Location

Headquarters

HQ city
Chongqing
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Meierbei.com business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Platform Commission/Transaction Fee: As a medical aesthetics marketplace platform, Meierbei earns revenue by facilitating transactions between users and partner medical institutions. The platform connects users with 2000+ hospitals and 12,000+ doctors, earning commissions on successful matches and service completions.
  2. Premium Membership Services: High-end membership services providing exclusive benefits including priority consultation, special pricing, and enhanced after-sales support. Premium members receive dedicated concierge services throughout their medical aesthetics journey.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Meierbei.com product offering

Product offering

Core offering

Meierbei.com is a high-end medical aesthetics selection platform that connects individual consumers with vetted partner hospitals and licensed doctors for cosmetic and plastic surgery procedures. The platform offers 1-on-1 pre-surgery, in-surgery, and post-surgery consultation services via 350+ professional aesthetics consultants, hospital/doctor matching, price comparison, customized treatment plans, authentic product verification, and after-sales follow-up.

Product overview

Meierbei.com operates as a unified medical beauty platform ecosystem consisting of three main products: the Meibei Medical Beauty Platform (美呗医美平台) as the core platform, the Meibei.com website (美呗网) as the web portal, and the Meibei mobile application (美呗APP) for on-the-go access. The platform functions as a medical aesthetic marketplace connecting users with over 2,000 partner hospitals and 12,000+ licensed doctors, offering services including 1-to-1 consultation, hospital selection, price comparison, and after-sales support across 34 provinces in China.

Differentiator

Problem solved

Functional benefit

Brands

  • 美呗网 (Meibei Website): Online medical aesthetics consulting service platform offering hospital/doctor comparison, pricing comparison, customized plans, and authentic product recommendations.
  • 美呗颜究院 (Meierbei Research Institute)
  • 美呗APP
  • 美呗美钻 (Meierbei Diamond)

Products and services

  • Meibei Medical Beauty Platform (美呗医美平台) The core online platform that helps users answer plastic surgery questions, filter quality hospitals, compare facility prices, customize medical aesthetic plans, and select authentic medical beauty projects. It is the primary product of the company.
  • Meibei.com Website (美呗网) The official web portal of the Meibei medical beauty platform, providing browser-based access to medical consultation, hospital matching, price comparison, and service booking for individual consumers.
  • Meibei Mobile App (美呗APP)
  • 1-on-1 Medical Aesthetics Consultation Service A personalized consultation service delivered by 350+ professional medical aesthetics consultants, available 24/7 year-round, covering pre-surgery Q&A, in-surgery support, and up to 6 months of post-procedure follow-up, targeted at individual medical aesthetics consumers.
  • Premium Membership Services (高端会员尊享服务)
  • Meibei Diamond Institution List (美呗美钻机构榜单) A premium curation/listing product launched in April 2021 that applies a 6-dimensional, 55-criteria evaluation framework with less than 1% acceptance rate to identify and rank top-tier medical aesthetics institutions for consumers.

Quantifiable outcome

  • Nearly 80% of China's 5A medical aesthetics institutions are partnered with Meierbei (39 out of 51)
  • +3 more outcomes

Companies that use Meierbei.com

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Meierbei.com technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Meierbei.com partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Hua Xi Bio (华熙生物)coreStrategic or Co-development Partner · 1 January 2020In 2020, Meierbei entered a strategic partnership with Hua Xi Bio, a leading hyaluronic acid manufacturer. The partnership focuses on product procurement, consumer demand analysis, and product design collaboration to ensure quality control and safety across all consumer touchpoints. This partnership supports Meierbei's 'Strict Selection of Authentic Products' initiative.
  • Partner Medical Institutions (2000+)coreChannel Partner/ Reseller/ DistributorMeierbei partners with 2000+ compliant medical institutions across 34 provinces. All partner institutions must pass the 6-dimension, 26-criteria review with less than 10% annual approval rate. Nearly 80% of China's 5A medical aesthetics institutions (39 of 51) are partnered with Meierbei.
  • Partner Doctors (12000+)coreChannel Partner/ Reseller/ DistributorMeierbei collaborates with 12,000+ qualified doctors who possess valid medical practitioner certificates (医师执业证 and 医师资格证). Foreign doctors must also hold the Foreign Doctor Short-term Practice Permit. Anesthesiologists are also required to have proper certifications.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Meierbei.com competitors and assessment

Company assessment

Direct peers

  • SoYoung International (新氧): NASDAQ-listed Chinese medical aesthetics internet platform that facilitates user discovery of cosmetic treatment providers, doctor reviews, and bookings. Directly competes with Meierbei as the other major player in China's medical aesthetics marketplace space, serving the same consumer and institutional customers with a similar content-plus-matching model.
  • Gengmei (更美): Chinese medical aesthetics platform offering hospital discovery, doctor matching, and booking services. Competes head-on with Meierbei in the same domestic segment, targeting consumer demand for cosmetic procedure selection and comparison.
  • RealSelf: US-based medical aesthetics platform providing doctor/institution discovery, reviews, and consumer education for cosmetic procedures. Operates a comparable content-led, trust-driven marketplace model targeting the same medical aesthetics consumer use case in a different geography.

Broad incumbents

  • Alma Lasers: Global manufacturer of medical and aesthetic laser, light, and ultrasound devices used by clinics and medical aesthetic institutions. Operates upstream in the same value chain Meierbei intermediates, with reach into the same institutional clients.
  • AbbVie / Allergan Aesthetics: Global aesthetics pharmaceutical leader (Botox, fillers, skincare) supplying products consumed in aesthetic procedures. Adjacent to Meierbei's selective product supply chain and the institutions transacted on its platform.
  • Alibaba Health (阿里健康): Major Chinese digital health and pharmaceutical e-commerce platform operated by Alibaba. Overlaps with Meierbei in digitizing healthcare consumer journeys and could enter medical aesthetics matchmaking as part of its broader healthcare marketplace.

Emerging players

  • Zwivel: Online consultation and matching platform that connects consumers with cosmetic doctors for virtual consultations and treatment planning. Overlaps with Meierbei's 1-on-1 pre-surgery consultation role, though focused on the US market and an earlier-stage offering.

Others

  • Bloomage Bio (华熙生物): Leading Chinese hyaluronic acid manufacturer and an existing strategic partner of Meierbei (product procurement, demand analysis, design collaboration). Enables Meierbei's authentic-product selection pillar and represents an upstream supply relationship in the same industry value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Meierbei.com financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Meierbei.com leadership team

Management profile

Number of profiles

Profiles3 records

Meierbei.com funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Meierbei.com M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meierbei.com

What does Meierbei.com do?

Meierbei.com is a high-end medical aesthetics selection platform that connects individual consumers with vetted partner hospitals and licensed doctors for cosmetic and plastic surgery procedures. The platform offers 1-on-1 pre-surgery, in-surgery, and post-surgery consultation services via 350+ professional aesthetics consultants, hospital/doctor matching, price comparison, customized treatment plans, authentic product verification, and after-sales follow-up.

Is Meierbei.com a public or private company?

Meierbei.com is a private company. It is classified as venture growth investor backed and is currently operating.

When was Meierbei.com founded?

Meierbei.com was founded in 2011. It employs 11 to 50 people.

Where is Meierbei.com based?

Meierbei.com is headquartered in Chongqing, China, in the Asia region.

How does Meierbei.com make money?

Two revenue lines are on record. Platform Commission/Transaction Fee is the primary driver. The others are premium Membership Services.

Who are Meierbei.com's main competitors?

Direct peers on record are SoYoung International (新氧), Gengmei (更美) and RealSelf. Broad incumbents are Alma Lasers, AbbVie / Allergan Aesthetics and Alibaba Health (阿里健康). Zwivel is listed as an emerging player. Bloomage Bio (华熙生物) is listed as an others.

Does Meierbei.com have an API?

No public API is recorded for Meierbei.com.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales